查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571608

營養基因組學市場規模、佔有率和趨勢分析報告：2024-2030 年按應用、產品、方法、最終用途、地區和細分市場進行的預測

Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Product, By Technique, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

營養基因組學市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球營養基因組市場規模將達到14億美元，2024年至2030年複合年成長率為17.4%。

這種成長是由於肥胖和心血管疾病（CVD）的增加，特別是在已開發地區。營養基因組學可以透過提供基於基因的個人化飲食在預防肥胖方面發揮重要作用。隨著老年人口的增加，人們對該產品的認知不斷提高，也將支持市場的成長。

營養基因組學中的肥胖和癌症研究應用將在 2023 年成為市場領導，預計將保持其主導地位，並在預測期內以顯著的複合年成長率擴張。由於肥胖病例的增加和老年人口的增加，預計包括亞太地區、拉丁美洲和中東在內的新興市場也將迅速擴張。

營養基因組學市場報告亮點

  • 2023年全球營養基因組市場規模將達4.482億美元，預計2024年至2030年複合年成長率為17.4%。
  • 預計肥胖應用領域將在2023年引領市場，並在2030年佔產業佔有率的38%。
  • 癌症研究預計將成為營養基因組學成長最快的應用，預測期內複合年成長率為 18.0%。
  • 預計北美將在 2023 年佔據最大市場佔有率，並在未來保持主導地位。
  • 在糖尿病、肥胖症和心臟病等慢性病盛行率不斷上升的推動下，亞太地區營養基因組學市場預計將以 18.1% 的速度快速成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章營養基因組學市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 營養基因體學市場分析工具
    • 波特的分析
    • PESTEL分析

第4章營養基因體學市場：應用估算與趨勢分析

  • 細分儀表板
  • 營養基因體學市場：2023 年和 2030 年應用變化分析
  • 肥胖
  • 心血管疾病
  • 癌症研究
  • 其他

第5章營養基因體學市場：產品評估與趨勢分析

  • 細分儀表板
  • 營養基因體學市場：2023 年和 2030 年產品變異分析
  • 試劑和套件
  • 服務

第6章營養基因體學市場：技術評估與趨勢分析

  • 細分儀表板
  • 營養基因體學市場：2023 年和 2030 年技術變化分析
  • 唾液
  • 頰黏膜拭子
  • 血

第7章營養基因組學市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 營養基因體學市場：最終用途變異分析，2023 年和 2030 年
  • 醫院/診所
  • 其他

第8章營養基因組學市場：區域估計和趨勢分析

  • 2023 年及 2030 年營養基因體學市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Nutrigenomix
    • The Gene Box
    • Metagenics
    • Xcode Life
    • GX Sciences, LLC（Fagron）
    • Cura Integrative Medicine
    • dnalife
    • Genova Diagnostics（GDX）
    • HOLISTIC HEALTH INTERNATIONAL, LLC
簡介目錄
Product Code: GVR-2-68038-791-9

Nutrigenomics Market Growth & Trends:

The global nutrigenomics market size is expected to reach USD 1.4 billion by 2030 registering a CAGR of 17.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-based diet. Increased awareness about the product along with growing geriatric population will also augment the market growth.

Obesity and cancer research applications of nutrigenomics emerged as the market leaders in 2023 and are expected to maintain the dominance expanding at a significant CAGR over the forecast period. Developing regional markets including Asia Pacific, Latin America, and Middle East are also expected to witness rapid expansion owing to the increased cases of obesity and growing geriatric population.

Nutrigenomics Market Report Highlights:

  • The global nutrigenomics market size was valued at USD 448.2 million in 2023 and is projected to grow at a CAGR of 17.4% from 2024 to 2030
  • Obesity application segment led the market in 2023 and is estimated to account for a 38% of the industry share by 2030
  • Cancer research is projected to be the fastest-growing application of nutrigenomics over the forecast period, registering a CAGR of 18.0%.
  • North America accounted for the largest market share in 2023 and is estimated to maintain its dominance over the years to come
  • Asia Pacific nutrigenomics market is expected to experience the fastest growth of 18.1%, driven by the increasing prevalence of chronic diseases such as diabetes, obesity, and heart disease

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Nutrigenomics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Nutrigenomics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Nutrigenomics Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nutrigenomics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Obesity
    • 4.3.1. Obesity Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Cardiovascular Diseases
    • 4.4.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Cancer Research
    • 4.5.1. Cancer Research Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Nutrigenomics Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Nutrigenomics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Reagents & Kits
    • 5.3.1. Reagents &Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Services
    • 5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Nutrigenomics Market: Technique Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Nutrigenomics Market: Technique Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Saliva
    • 6.3.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Buccal Swab
    • 6.4.1. Buccal Swab Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Blood
    • 6.5.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Nutrigenomics Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Nutrigenomics Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Nutrigenomics Market: Regional Estimates & Trend Analysis

  • 8.1. Nutrigenomics Market Share, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Nutrigenomics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Nutrigenomix
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/Strategic Initiatives
    • 9.4.2. The Gene Box
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/Strategic Initiatives
    • 9.4.3. Metagenics
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/Strategic Initiatives
    • 9.4.4. Xcode Life
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/Strategic Initiatives
    • 9.4.5. GX Sciences, LLC (Fagron)
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/Strategic Initiatives
    • 9.4.6. Cura Integrative Medicine
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/Strategic Initiatives
    • 9.4.7. dnalife
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/Strategic Initiatives
    • 9.4.8. Genova Diagnostics (GDX)
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/Strategic Initiatives
    • 9.4.9. HOLISTIC HEALTH INTERNATIONAL, LLC
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/Strategic Initiatives